170 related articles for article (PubMed ID: 32971118)
21. Cloning and molecular characterization of telomerase reverse transcriptase (TERT) and telomere length analysis of Peromyscus leucopus.
Zhao X; Ueda Y; Kajigaya S; Alaks G; Desierto MJ; Townsley DM; Dumitriu B; Chen J; Lacy RC; Young NS
Gene; 2015 Aug; 568(1):8-18. PubMed ID: 25962353
[TBL] [Abstract][Full Text] [Related]
22. TERT promoter mutations and telomeres during tumorigenesis.
Lorbeer FK; Hockemeyer D
Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
[TBL] [Abstract][Full Text] [Related]
23. Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Leão R; Lee D; Figueiredo A; Hermanns T; Wild P; Komosa M; Lau I; Mistry M; Nunes NM; Price AJ; Zhang C; Lipman T; Poyet C; Valtcheva N; Oehl K; Coelho H; Sayyid R; Gomes AM; Prado E Castro L; Sweet J; Vinagre J; Apolónio J; Stephens D; Faleiro I; Fadaak K; Richard PO; Kulkarni G; Zlotta AR; Hamilton RJ; Castelo-Branco P; Tabori U
Int J Cancer; 2019 Apr; 144(7):1676-1684. PubMed ID: 30350309
[TBL] [Abstract][Full Text] [Related]
24. Differential TERT promoter methylation and response to 5-aza-2'-deoxycytidine in acute myeloid leukemia cell lines: TERT expression, telomerase activity, telomere length, and cell death.
Pettigrew KA; Armstrong RN; Colyer HA; Zhang SD; Rea IM; Jones RE; Baird DM; Mills KI
Genes Chromosomes Cancer; 2012 Aug; 51(8):768-80. PubMed ID: 22517724
[TBL] [Abstract][Full Text] [Related]
25. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
26. Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.
Ferreira MSV; Sørensen MD; Pusch S; Beier D; Bouillon AS; Kristensen BW; Brümmendorf TH; Beier CP; Beier F
J Neurooncol; 2020 Mar; 147(1):1-14. PubMed ID: 31960234
[TBL] [Abstract][Full Text] [Related]
27. The TERT Promoter: A Key Player in the Fight for Cancer Cell Immortality.
Hasanau TN; Pisarev EP; Kisil OV; Zvereva ME
Biochemistry (Mosc); 2023 Jan; 88(Suppl 1):S21-S38. PubMed ID: 37069112
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation of the TERT promoter and its impact on human cancer.
Lee DD; Komosa M; Nunes NM; Tabori U
Curr Opin Genet Dev; 2020 Feb; 60():17-24. PubMed ID: 32114294
[TBL] [Abstract][Full Text] [Related]
30. Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas.
Gregório C; Thakur S; Camara Rivero R; Márcia Dos Santos Machado S; Cuenin C; Carreira C; White V; Cree IA; Vukojevic K; Glavina Durdov M; Bersch Osvaldt A; Ashton-Prolla P; Herceg Z; Talukdar FR
Gene; 2023 Jul; 873():147460. PubMed ID: 37150235
[TBL] [Abstract][Full Text] [Related]
31. Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.
Hirokawa T; Arimasu Y; Chiba T; Nakazato Y; Fujiwara M; Kamma H
Pathobiology; 2020; 87(6):338-344. PubMed ID: 33227798
[TBL] [Abstract][Full Text] [Related]
32. [Telomerase activity, mTert gene expression and the telomere length in mouse mesenchymal stem cells in the late period after γ- and γ,n-irradiation and in the tumors developed from these cells].
Vysotskaya OV; Glukhov AI; Semochkina YP; Gordeev SA; Moskaleva EY
Biomed Khim; 2020 May; 66(3):265-273. PubMed ID: 32588833
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Stögbauer L; Stummer W; Senner V; Brokinkel B
Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.
Kubuki Y; Suzuki M; Sasaki H; Toyama T; Yamashita K; Maeda K; Ido A; Matsuoka H; Okayama A; Nakanishi T; Tsubouchi H
Leuk Lymphoma; 2005 Mar; 46(3):393-9. PubMed ID: 15621829
[TBL] [Abstract][Full Text] [Related]
35. hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer.
Barczak W; Suchorska WM; Sobecka A; Bednarowicz K; Machczynski P; Golusinski P; Rubis B; Masternak MM; Golusinski W
Mol Med Rep; 2017 Jul; 16(1):441-446. PubMed ID: 28535013
[TBL] [Abstract][Full Text] [Related]
36. TERT-Regulation and Roles in Cancer Formation.
Dratwa M; Wysoczańska B; Łacina P; Kubik T; Bogunia-Kubik K
Front Immunol; 2020; 11():589929. PubMed ID: 33329574
[TBL] [Abstract][Full Text] [Related]
37. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity, telomere length and hTERT DNA methylation in peripheral blood mononuclear cells from monozygotic twins with discordant smoking habits.
Marcon F; Siniscalchi E; Andreoli C; Allione A; Fiorito G; Medda E; Guarrera S; Matullo G; Crebelli R
Environ Mol Mutagen; 2017 Oct; 58(8):551-559. PubMed ID: 28843010
[TBL] [Abstract][Full Text] [Related]
39. The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.
Diplas BH; He X; Brosnan-Cashman JA; Liu H; Chen LH; Wang Z; Moure CJ; Killela PJ; Loriaux DB; Lipp ES; Greer PK; Yang R; Rizzo AJ; Rodriguez FJ; Friedman AH; Friedman HS; Wang S; He Y; McLendon RE; Bigner DD; Jiao Y; Waitkus MS; Meeker AK; Yan H
Nat Commun; 2018 May; 9(1):2087. PubMed ID: 29802247
[TBL] [Abstract][Full Text] [Related]
40. Regulation of telomere length and homeostasis by telomerase enzyme processivity.
D'Souza Y; Lauzon C; Chu TW; Autexier C
J Cell Sci; 2013 Jan; 126(Pt 2):676-87. PubMed ID: 23178942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
